Cancer drug Avastin does not offer value for money, says Nice - Health News - Health & Families - The Independent

Cancer drug Avastin does not offer value for money, says Nice

 

A drug will not be made routinely available on the NHS for women with breast cancer from today after a watchdog ruled that it does not help improve patients' quality of life or provide value for money.

New guidance for doctors issued by the National Institute for Health and Clinical Excellence (Nice) does not recommend Avastin (bevacizumab) to treat women with the disease, it said.

The drug works by starving cancerous tumours of blood and was being looked at as a treatment in combination with capecitabine, a type of chemotherapy, for breast cancer that had metastasised to other parts of the body.

The advisory body said that making Avastin available on the NHS was not a good use of resources because of its high cost, and the lack of evidence to show patients would have a better quality of life than if they were treated with chemotherapy alone.

Sir Andrew Dillon, Nice's chief executive, said: "We can't recommend a drug that has not been shown to work as well as, or better than, current treatments and costs much more.

"Evidence presented to the independent appraisal committee did not conclusively show that bevacizumab, in combination with capecitabine, could improve overall survival or improve a patient's quality of life more than current treatment.

"These uncertainties combined with the high cost of bevacizumab mean the drug simply isn't cost-effective.

"I understand this news will be disappointing to people, especially those with breast cancer that has spread elsewhere in their body. However, Nice recommends a range of treatments that the NHS can use to treat metastatic disease and these are outlined in our clinical guideline on the diagnosis and treatment of advanced breast cancer."

Nice said that it is the responsibility of NHS trusts to make decisions locally on the funding of treatment.

If doctors feel that a particular patient is likely to benefit from a treatment not recommended by Nice, they can apply on behalf of their patient to an "exceptional case" committee or to the Cancer Drugs Fund.

Avastin was being looked at for cancer patients for whom treatment with other chemotherapy options was "not considered appropriate", a spokeswoman said.

In December last year the US Food and Drug Administration announced it was recommending the removal of the breast cancer indication from the label for Avastin after it was not shown to be safe and effective for that use.

It said the risks include severe high blood pressure; bleeding and haemorrhage; the development of "holes" in parts of the body such as the nose and stomach, and heart attack or heart failure.

The agency reviewed four clinical studies of Avastin in women with breast cancer and found the drug does not prolong overall survival or provide a sufficient benefit in slowing disease progression to outweigh the "significant risk" to patients.

Dr Rachel Greig, senior policy officer at Breakthrough Breast Cancer, said: "We welcome new treatments for women with metastatic breast cancer as we know their options are limited and prolonging life is incredibly important to them and their families.

"However, we understand it was a difficult decision for Nice to make as this treatment combination can cause serious side effects and there is no evidence to show how this may affect a patient's quality of life."

Roche, which manufactures Avastin, said it was disappointed by the decision and criticised the way that Nice had reviewed data about the drug's effectiveness.

A company spokeswoman said the drug, when used with capecitabine, was "proven to be an important treatment option for women who have a particularly aggressive form of breast cancer which has a poor prognosis".

"The decision by Nice means women in England with advanced breast cancer and who have limited treatment options available to them will instead have to rely on their clinicians' successful application to the Cancer Drugs Fund in order to receive treatment with Avastin.

"However, there is no similar access to Avastin for patients in Wales, Scotland and Northern Ireland as yet," she said.

"Avastin has a well-established tolerability profile and the most frequently observed side effects in clinical trials were hypertension, fatigue, neuropathy and proteinuria.

"The most common side effects are manageable, with hypertension for example being treated with conventional antihypertensive medication."

PA

News
Paper trail: the wedding photograph found in the rubble after 9/11 – it took Elizabeth Keefe 13 years to find the people in it
newsWho are the people in this photo? It took Elizabeth Stringer Keefe 13 years to find out
Arts and Entertainment
Evil eye: Douglas Adams in 'mad genius' pose
booksNew biography sheds light on comic genius of Douglas Adams
Sport
FootballFull debuts don't come much more stylish than those on show here
News
i100
PROMOTED VIDEO
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Life and Style
ebooksFrom the lifespan of a slug to the distance to the Sun: answers to 500 questions from readers
Life and Style
Kim Kardashian drawn backlash over her sexy swimsuit selfie, called 'disgusting' and 'nasty'
fashionCritics say magazine only pays attention to fashion trends among rich, white women
Arts and Entertainment
TVShows like Agents of S.H.I.E.L.D are little more than marketing tools
Arts and Entertainment
Hit the roof: hot-tub cinema east London
architectureFrom pools to football pitches, rooftop living is looking up
Travel
travel
News
The ecological reconstruction of Ikrandraco avatar is shown in this illustration courtesy of Chuang Zhao. Scientists on September 11, 2014 announced the discovery of fossils in China of a type of flying reptile called a pterosaur that lived 120 millions years ago and so closely resembled those creatures from the 2009 film, Avatar that they named it after them.
SCIENCE
Life and Style
tech
Arts and Entertainment
Matisse: The Cut-Outs exhibition attracted 562,000 visitors to the Tate Modern from April to September
art
Life and Style
Models walk the runway at the Tom Ford show during London Fashion Week Spring Summer 2015
fashionLondon Fashion Week 2014
News
Kenny G
news
News
peopleThe black actress has claimed police mistook her for a prostitute when she kissed her white husband
Life and Style
techIndian model comes with cricket scores baked in
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Energy Markets Analyst

    £400000 Per Annum: The Green Recruitment Company: Job Title: Energy Markets An...

    Junior Web Analyst – West Sussex – Up to £35k DOE

    £30000 - £35000 Per Annum Plus excellent benefits: Clearwater People Solutions...

    Nursery Manager

    £22000 - £23000 per annum: Randstad Education Bristol: We are currently recrui...

    Web Analyst – Permanent – Up to £40k - London

    £35000 - £40000 Per Annum: Clearwater People Solutions Ltd: We are currently r...

    Day In a Page

    Mystery of the Ground Zero wedding photo

    A shot in the dark

    Mystery of the wedding photo from Ground Zero
    His life, the universe and everything

    His life, the universe and everything

    New biography sheds light on comic genius of Douglas Adams
    Save us from small screen superheroes

    Save us from small screen superheroes

    Shows like Agents of S.H.I.E.L.D are little more than marketing tools
    Reach for the skies

    Reach for the skies

    From pools to football pitches, rooftop living is looking up
    These are the 12 best hotel spas in the UK

    12 best hotel spas in the UK

    Some hotels go all out on facilities; others stand out for the sheer quality of treatments
    These Iranian-controlled Shia militias used to specialise in killing American soldiers. Now they are fighting Isis, backed up by US airstrikes

    Widespread fear of Isis is producing strange bedfellows

    Iranian-controlled Shia militias that used to kill American soldiers are now fighting Isis, helped by US airstrikes
    Topshop goes part Athena poster, part last spring Prada

    Topshop goes part Athena poster, part last spring Prada

    Shoppers don't come to Topshop for the unique
    How to make a Lego masterpiece

    How to make a Lego masterpiece

    Toy breaks out of the nursery and heads for the gallery
    Meet the ‘Endies’ – city dwellers who are too poor to have fun

    Meet the ‘Endies’ – city dwellers who are too poor to have fun

    Urbanites are cursed with an acronym pointing to Employed but No Disposable Income or Savings
    Paisley’s decision to make peace with IRA enemies might remind the Arabs of Sadat

    Ian Paisley’s decision to make peace with his IRA enemies

    His Save Ulster from Sodomy campaign would surely have been supported by many a Sunni imam
    'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

    'She was a singer, a superstar, an addict, but to me, her mother, she is simply Amy'

    Exclusive extract from Janis Winehouse's poignant new memoir
    Is this the role to win Cumberbatch an Oscar?

    Is this the role to win Cumberbatch an Oscar?

    The Imitation Game, film review
    England and Roy Hodgson take a joint step towards redemption in Basel

    England and Hodgson take a joint step towards redemption

    Welbeck double puts England on the road to Euro 2016
    Relatives fight over Vivian Maier’s rare photos

    Relatives fight over Vivian Maier’s rare photos

    Pictures removed from public view as courts decide ownership
    ‘Fashion has to be fun. It’s a big business, not a cure for cancer’

    ‘Fashion has to be fun. It’s a big business, not a cure for cancer’

    Donatella Versace at New York Fashion Week